Public Health Agency of Canada / Agence de santé publique du Canada
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m Skip all navigation -accesskey z
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
    Public Health Agency of Canada (PHAC)
    logoPaediatrics & Child Health
   

THE JOURNAL OF THE CANADIAN PAEDIATRIC SOCIETY

Canadian selected publications, 1997 to 1999

  1. An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on Japanese encephalitis vaccine. Can Commun Dis Rep 1998;24(Aug 15):1-8.

  2. Statement on oral cholera vaccination. Can Commun Dis Rep 1998;24:1-4.

  3. Alexander D. The effect of a computerized patient recall list on pneumococcal and influenza vaccination rates. Public Health Epidemiol Rep Ont 1998;9:81-90.

  4. Ames H. Hepatitis B vaccination. J Can Dent Assoc 1998;64:612.

  5. Andrews R, Kempe A, Sinn K, et al. Vaccinating children with a history of serious reactions after vaccination or of eggs allergy.
    Med J Aust 1998;168:491-4.

  6. Arnot R. The evolving efforts to control hepatitis B virus. Pediatr Infect Dis J 1998;17(Suppl 7):S26-9.

  7. Bell A, Fyfe M, Bigham M, et al. Outbreak of mumps among young adults - Vancouver, British Columbia. Can Commun Dis Rep 1997;23:169-72.

  8. Bentsi-Enchill A. Varicella-zoster virus disease and epidemiology: seeking better control strategies - Part 1. Can Commun Dis Rep 1998;24:193-8.

  9. Bjornson G, Scheifele D, Lajeunesse C, et al. The effect of reminder notices on the timeliness of early childhood immunization. BC Health Dis Surveillance 1997;6:114-7.

  10. Buck P, Herman S, Scott C, et al. Influenza in Canada - 1997-1998 season. Can Commun Dis Rep
    1998;24:169-76.

  11. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Respiratory syncytial virus immune globulin intravenous. Can J Infect Dis 1998;9:12-5.

  12. Deeks S, Johnson I. Vaccine coverage during a school-based hepatitis B immunization program. Can J Public Health 1998;89:98-101.

  13. Delage G. Immunization coverage rates still need improvement. Paediatr Child Health 1998;3:73.

  14. Deshaies D, Dion R, Valiquette L, Auger. Immunization against hepatitis A during an outbreak in a Jewish orthodox community - Quebec, 1997-1998. Can Commun Dis Rep 1998;24:145-51.

  15. Division of Immunization, Bureau of Infectious Diseases, Canadian consensus - conference on a national immunization records system. Can Commun Dis Rep 1998;24:137-44.

  16. Edouard L. Reform of well-baby services. Can Fam Physician 1997;43:1195-6.

  17. Elkin B. Reportable diseases in the NWT: Anthrax. Epidemiol North 1998;10:14-5.

  18. Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada 1990-1994.
    Can Commun Dis Rep 1998;24:105-12.

  19. Fortin A, Milord F. Hepatitis A in restaurant clientele and staff - Quebec. Can Commun Dis Rep 1998;24:53-8.

  20. Gay NJ, Pelletier L, Duclos P. Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy. Vaccine 1998;16:794-801.

  21. Grewal S, Scheifele D. Haemophilus influenzae type B disease at 11 pediatric centres, 1996-1997. Can Commun Dis Rep 1998;24:105-12.

  22. Gyorkos TW, Tannenbaum TN, Abrahamowicz M, Delage G, Carsley J, Marchand S. Evaluation of rubella screening in pregnant women. CMAJ 1998;159:1091-7.

  23. Halperin B, Eastwood B, Halperin S. Comparison of parental and health care - professional references for the acellular or whole cell pertussis vaccine. Pediatric Infect Dis J 1998;17:103-9.

  24. Halperin S. Acellular pertussis vaccines have arrived. Paediatr Child Health 1997;2:17-8.

  25. Horn D, Mestery K. Manitoba gets chickenpox. CDC Manitoba Stat Rep 1998;Jan:2.

  26. Interscience Conference on Antimicrobial Agents and Chemotherapy. Hepatitis B Virus: the quest for global control and eradication (proceedings). Pediatr Infect Dis J 1998;17(Suppl 7):S25-47.

  27. Jochem K, Tannenbaum TN, Menzies D. Prevalence of tuberculin skin test reactions among prison workers. Can J Public Health 1997;88:202-6.

  28. Law BJ, Rosenberg T, MacDonald NE, et al. Age-related immunogenicity of meningococcal polysaccharide vaccine in aboriginal children and adolescents living in a northern Manitoba reserve community. Pediatr Infect Dis J 1998;17:860-4.

  29. Li Y. 1997-1998 influenza season: Canadian laboratory diagnoses and strain characterization. Can Commun Dis Rep 1999;25:9-12.

  30. Lindsay R, Artsob H, Barker I. Distribution of Ixodes pacificus and Ixodes scapularis re concurrent babesiosis and Lyme disease. Can Commun Dis Rep 1998;24:121-8.

  31. MacDonald N. Rotavirus infections: is the time right for more changes? Paediatr Child Health 1998;3:156-7.

  32. MacLean J, Ward B. First the bad news. CMAJ 1997;157:1675-6.

  33. McDermott C. Measles elimination program in Alberta, why the province is launching a second dose measles campaign this year. AARN Newslet 1997;53:8-32.

  34. Menzies D. Issues in management of contacts of patients with active pulmonary tuberculosis. Can J Public Health 1997;88:197-201.

  35. Miller J, Tam T, Afif C, et al. Influenza A outbreak on a cruise ship. Can Commun Dis Rep 1998;24:9-10.

  36. Mitchell LA, Nsubuga J, Kiefer L. Serologic responses to measles, mumps, and rubella (MMR) vaccine in health infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR. Can J Public Health 1998;89:325-8.

  37. Guidelines for Childhood Immunization Practices. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep 1997;23:1-12.

  38. National Advisory Committee on Immunization. Statement on influenza vaccination for the 1998-1999 season. Can Commun Dis Rep 1998;24:1-12.

  39. Nsubuga J,  Duclos P, Daly P. Summary report of the Ontario influenza 1997-98 Season. Public Health Epidemiol Ont 1998;9:230-41.

  40. Ochnio J, Scheifele D, Lightle G, et al. Hepatitis A is uncommon among children in Vancouver: results of an antibody prevalence survey in grade six students. BC Health Dis Surveillance 1997;6:131-3.

  41. Pelletier L, Chung P, Duclos P, Manga P, Scott J. A benefit-cost analysis of two-dose measles immunization in Canada. Vaccine 1998;16:989-95.

  42. Pelletier L, Duclos P, Daly P. Evaluation of the promotional materials used during the measles mass immunization campaign in Ontario and British Columbia. Can J Public Health 1998;895:329-32.

  43. Public and Preventative Health Division. Notifiable Disease Statistics. BC Health Dis Surveillance 1998;7:101-12.

  44. Public Health & Medical Services. Pertussis outbreak: update. New Brunswick Epidemiol Rep 1998;9:7-8.

  45. Reynolds D. How public health units fit in. Can Fam Physician  1997;43:1711.

  46. Scheifele D. Point, counterpoint. CMAJ 1997;157:1705-6.

  47. Scheifele D, Law B, Jadavji T, et al. Disseminated bacille Calmette-Guérin infection: three recent Canadian cases. Can Commun Dis Rep 1998;24:69-76.

  48. Scheifele D. Universal childhood hepatitis B vaccination: infants vs preadolescents. The Canadian perspective. Pediatric Infect Dis J 1998;17(Suppl 7):35-7.

  49. Sellors J, Pickard L, Mahony J, et al. Understanding and enhancing compliance with the second dose of hepatitis B vaccine: a cohort analysis and a randomized controlled trial. CMAJ 1997;157:143-8.

  50. Sockett PN. Canadian Paediatric Surveillance Program: Two years of a system for investigating unusual paediatric disorders. Paediatr Child Health 1998;3:240-5.

  51. Spika JS, Kertesz D, Deeks S, Talbot J. [Pneumococcal infection and anti-pneumococcal vaccination programs in Canada.] Presse Med 1998;27(Suppl 1):39-42. (French)

  52. Squires SG, Spika JS. Protecting against invasive pneumococcal disease: be wise - immunize! CMAJ 1998;159:826-7.

  53. Stewart P, MacDonald N, Manion I. School-based hepatitis B immunization program: follow-up of non-participants at first school clinic. Can J Public Health 1997;88:192-6.

  54. Strathdee S, Schechter M. One step forward, two steps back. CMAJ 1997;157:1699-700.

  55. Sutcliffe P. Rees K. Rabies in Churchill. CDC Manitoba Stat Rep 1998;Jan:1.

  56. Sweet SD, McGrath PJ. Relative importance of mother's versus medical staffs' behavior in the prediction of infant immunization pain behavior. J Pediatr Psychol 1998;23:249-56.

  57. Tam T, Bentsi-Enchill A. The return of the 100-day cough: resurgence of pertussis in the 1990s. CMAJ 1998;159:695-6.

  58. Tam TW. Following up on unfinished business - prenatal rubella screening and postpartum vaccination. CMAJ 1998;159:1117-8.

  59. Tamblyn S. Preventing influenza outbreaks in long-term care facilities. CMAJ 1997;157:927-8.

  60. Tamblyn S. Pneumococcal vaccine: overcoming barriers to use. CMAJ 1998;158:87-8.

  61. Thiam I. Canadian immunization cuts will cause child deaths. Can Fam Physician 1997;43:1203.

  62. Thomas R. Preventing pneumococcal disease. Can Fam Physician 1998;44:2180-1, 2184-5.

  63. Warbeck J, Mestery K. Children with strep infections following chickenpox. CDC Manitoba Stat Rep 1998;Jan:2.

  64. Wiebe T, Fergusson P, Horne D, et al.  Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies. Med Decis Making 1997;17:472-82.

  65. Working Group on Measles Elimination in Canada. Measles surveillance: guidelines for laboratory support. Can Commun Dis Rep 1998;24:33-44.

  66. Working Group on Polio Eradication, Bentsi-Enchill A. Protocol for the investigation of acute flaccid paralysis and suspected paralytic poliomyelitis. Paediatr Child Health 1997;2:409-12.

  67. Yassi, A. Utilizing data systems to develop and monitor occupational health programs in a large Canadian hospital. Methods Infect Med 1998;37:125-9.

[Previous] [Table of Contents]

 

Last Updated: 2000-02-15 Top
Important Notices